Check two blood markers to help prevent preeclampsia
Part of Genetic & congenital, Heart & circulation, Women’s health & pregnancy clinical trials.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant for the first time (no prior births).
- This is one baby only (singleton pregnancy).
- You are over 18 years old.
- You are between 35.0 and 36.6 weeks pregnant.
- You can sign the study consent form in writing.
- You are not currently in another study that could change delivery timing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood-flow and artery health signs during pregnancy to better understand why preeclampsia happens. It compares women with preeclampsia to women with an uncomplicated pregnancy, and may help improve early detection and care.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
This study looks at two ways to manage early-onset fetal growth restriction (when a baby is smaller than expected). It compares using blood tests for angiogenic factors versus feto-placental Doppler ultrasound to guide care. The goal is to find the best way to monitor and protect your baby's health.
This trial is checking if certain proteins in your blood (called placental growth factor and nucleosomes) during early pregnancy can help predict problems like preeclampsia or preterm birth. If you join, you'll give a blood sample during your regular NIPT test, and researchers will follow your pregnancy to see how it goes.
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.